✦ LIBER ✦

Treatment of hepatitis C in the potential liver transplant recipient

✍ Scribed by Hui-Hui Tan; Thomas D. Schiano

Book ID: 107540499
Publisher: Current Science Inc.
Year: 2009
Tongue: English
Weight: 333 KB
Volume: 8
Category: Article
ISSN: 1540-3416
DOI: 10.1007/s11901-009-0012-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of hepatitis C virus in the li

Treatment of hepatitis C virus in the liver transplant recipient

✍ Lafaine Grant; Jeffrey S. Crippin 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 242 KB

Treatment of hepatitis C in liver transp

Treatment of hepatitis C in liver transplant recipients

✍ Fredric D. Gordon; Paul Kwo; Hugo E. Vargas 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 182 KB 👁 1 views

Recurrent hepatitis C after liver transplantation is a universal phenomenon. Graft reinfection occurs rapidly; once it is established, allograft cirrhosis and decompensation rapidly ensue in many patients. Treatment with pegylated interferon plus ribavirin is the standard of care among nontransplant

Rimantadine for treatment of hepatitis C

Rimantadine for treatment of hepatitis C infection in liver transplant recipients

✍ Sherman, Kenneth E. ;Sickler, Joelle ;Aranda-Michel, Jaime ;Weber, Frederick L. 📂 Article 📅 1999 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 61 KB 👁 2 views

Hepatitis C recurrence after liver transplantation is a serious problem, leading to increased graft loss and morbidity in some individuals. Treatment with interferon and other agents is controversial and not highly efficacious. The use of an effective antiviral agent to reduce or eliminate viral bur

Natural History and Treatment of Hepatit

Natural History and Treatment of Hepatitis C in Liver Transplant Recipients

✍ Kimberly A. Brown 📂 Article 📅 2010 🏛 Current Science Inc. 🌐 English ⚖ 223 KB

Treating hepatitis C infection in liver

Treating hepatitis C infection in liver transplant recipients

✍ Norah A. Terrault; Marina Berenguer 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 192 KB 👁 1 views

Chronic infection with hepatitis C virus (HCV) is a growing problem worldwide, with up to 300 million individuals infected, and those with chronic infection are at risk for cirrhosis and hepatocellular carcinoma. HCV infection is the most common indication for liver transplantation in the United Sta

Anemia in liver transplant recipients un

Anemia in liver transplant recipients undergoing antiviral treatment for recurrent hepatitis C

✍ Sammy Saab; Mina K. Oh; Ayman B. Ibrahim; Francisco Durazo; Steven Han; Hasan Ye 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB 👁 1 views

Adherence to antiviral therapy is essential to achieve sustained virological responses in patients treated for hepatitis C. An important limitation to use of appropriate doses of ribavirin is development of anemia. The aim of this study is to identify risk factors associated with anemia in liver tra